CELL INTELLIGENCE · 肿瘤细胞治疗研究

靶向急性髓系白血病中的表观遗传-免疫轴：当前进展与未来方向

Targeting the Epigenetic-Immune Axis in Acute Myeloid Leukemia: Current Advances and Future Directions.

靶向白血病干细胞的脂质体纳米免疫疗法通过沉默 B 细胞淋巴瘤 2 逆转免疫逃逸并抑制融合癌蛋白驱动的急性髓系白血病

Leukemic Stem Cell-Targeted Liposomal Nanoimmunotherapy Reverses Immune Evasion and Inhibits Fusion Oncoprotein-Driven Acute Myeloid Leukemia by Silen

NK 细胞免疫治疗儿童实体瘤的生产成本分析与探索性经济评估

Manufacturing cost analysis and exploratory economic evaluation of natural killer cell immunotherapy for paediatric solid tumors.

NK 细胞疗法显示出指示性的早期经济信号，值得进一步的临床和经济研究。微观成本核算识别出可操作的制造成本驱动因素，为工艺优化提供信息，这些探索性估计为随着临床证据发展而进行的迭代经济评估奠定了基础。

磁性纳米粒子作为癌症免疫治疗前沿的新兴趋势与未来展望

Emerging trends and future outlook towards magnetic nanoparticles as frontiers in cancer immunotherapy.

效应细胞衔接双特异性抗体用于癌症治疗：工程化精准免疫

Effector-cell-engaging bispecific antibodies for cancer therapeutics: Engineering precision immunity.

IL-10 在细胞毒性抗肿瘤免疫中的情境作用：证据、争议与治疗转化

IL-10's contextual role in cytotoxic antitumor immunity: evidence, controversies, and therapeutic translation.

二甲双胍在癌症治疗中调节肿瘤微环境和免疫反应的作用

Metformin's Role in Modulating the Tumor Microenvironment and Immune Response in Cancer Therapy.

嵌合 IL-15 作为下一代免疫治疗药物：疗效与安全性的临床前评估

Chimeric IL-15 as a next-generation immunotherapeutic: preclinical assessment of efficacy and safety.

CRC 中 SH3BP2 基因组改变与表达谱的计算机模拟分析

In silico analysis of SH3BP2 genomic alterations and expression profiles in CRC.

平行处理 T 细胞与 NK 细胞以增强体内 CAR-T 细胞对血液肿瘤和实体瘤的活性

Parallel processing of T cells and natural killer cells to enhance in vivoCAR T cell activity against blood and solid cancers.

本研究鼓励优化利用白细胞单采产物。通过将废弃的 PBMC 回收为 NK 细胞，可有效增强 CAR-T 细胞疗法，改善肿瘤清除率和生存率。